Wassil Nowicky
Nowicky Pharma-Ukrainian Anti-Cancer Institute, Austria
Biography
Wassil Nowicky is the Director of Nowicky Pharma and President of the Ukrainian Anti-Cancer Institute, Vienna, Austria. He has fi nished his study at the Radiotechnical Faculty of the Technical University of Lviv, Ukraine in 1955 with graduation in Diplom-Ingeniueur in 1960 with title nostrifi cated in Austria in 1975.
He became the very first scientist in the development of the anticancer protonic therapy and is the inventor of the preparation against cancer with a selective effect on basis of celandine alkaloids NSC-631570. He used the factor that cancer cells are more negative charged than normal cells and invented the celandine alkaloid with a positive charge thanks to which it accumulates in cancer cells very fast. He is an author of over 300 scientifi c articles dedicated to cancer research. He is a member of the New York Academy of Sciences, member of the European Union for Applied Immunology and of the American Association for scientifi c progress, Honorary Doctor of the Janka Kupala University in Hrodno, Doctor Honoris Causa of the Open International University on complex medicine in Colombo, Honorary Member of the Austrian Albert Schweitzer Society. He has received the award for merits of National guild of pharmacists of America; the award of Austrian Society of sanitary,hygiene and public health services and others.
Abstract
Abstract : Anti-cancer preparation NSC-631570 (Ukrain) and its effi cacy in the treatment of breast cancer